Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_assertion type Assertion NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_head.
- NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_assertion description "[Decreased or lost PTEN expression was characteristic of endometrial tumourigenesis (51/81, 63%, in EC compared with 24/62, 39%, in CRC, p = 0.004) and KRAS mutations of colorectal tumourigenesis (19/70, 27% in CRC vs. 9/89, 10%, in EC, p = 0.006) regardless of the MMR gene mutation status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_provenance.
- NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_assertion evidence source_evidence_literature NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_provenance.
- NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_assertion SIO_000772 17471559 NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_provenance.
- NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_assertion wasDerivedFrom befree-2016 NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_provenance.
- NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_assertion wasGeneratedBy ECO_0000203 NP607629.RAhVDv-A2BHdQyYmPmUXLx1xQ0Af_qT_XxmSQC2RLhGc4130_provenance.